Hypoxaemia in the early stage of COVID-19: prevalence of physical or biochemical factors?

Eur Respir Rev. 2022 Sep 20;31(165):220138. doi: 10.1183/16000617.0138-2022. Print 2022 Sep 30.

Abstract

The ventilation–perfusion mismatch can't explain the high PaCO2–PETCO2 gap in the setting of COVID-19 induced hypoxaemia and cannot be considered as the sole pathophysiological basis for the treatment in the early stage of COVID-19 https://bit.ly/3BKmGxJ

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Hypoxia / diagnosis
  • Hypoxia / epidemiology
  • Hypoxia / etiology
  • Prevalence
  • Respiratory Tract Infections* / epidemiology